Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci187202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Dae-Seok Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Adipocytes, Inflammation, Mammary Neoplasms, Experimental. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
Proinflammatory signaling in adipocytes is essential for healthy adipose expansion, remodeling, and tissue integrity. We investigated the effects of targeting inflammation in either adipocytes or mammary gland epithelial cells, in the context of mammary tumor development, by locally expressing the antiinflammatory adenoviral RIDα/β protein complex in a cell type–specific manner. Suppression of adipocyte inflammation (RID ad mice) in a mammary tumor model driven by MMTV-PyMT (PyMT-RID ad mice) led to an elevated number of tumor-associated macrophages and upregulation of immunoregulatory molecules in the mammary fat pad. This was accompanied by metabolic dysfunction and abnormal mammary gland development. Importantly, this phenotype correlated with accelerated mammary tumor onset, enhanced growth, and lung metastasis. Tumors in PyMT-RID ad mice exhibited upregulated CD36 expression, suggesting enhanced fatty acid uptake. Conversely, suppression of inflammation in mammary gland epithelial cells by RIDα/β expression (RID MMTV mice) decelerated mammary tumor growth without affecting tumor onset or macrophage accumulation. These findings highlight the differential impact on tumor development exerted through the suppression of inflammatory signals in different cell types in the microenvironment. Our results underscore the role of the suppression of adipocyte inflammation leading to a tumor-friendly microenvironment, promoting mammary cancer progression. This study sheds light on the complex interplay between inflammation, specifically driven by the adipocyte, in breast cancer pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Adipose Management, Osaka University Graduate School of Medicine, Osaka, Japan.
- Barnstable Brown Diabetes and Obesity Center, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
- Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, South Korea.
- Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NIH HHS
- NIH
- American Heart Association
- NIDDK
Zitieren
APA
Kim, D. S., Onodera, T., Funcke, J. B., Min, K., Zhu, Q., Lin, Q., Chen, S., Joung, C., Kim, M., Wynn, R. M., Velasco, J., Lee, C., Virostek, M., Li, C., & Scherer, P. E. (2025). Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci187202
Vancouver
Kim DS, Onodera T, Funcke JB, Min K, Zhu Q, Lin Q, et al. Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci187202
BibTeX
@article{Kim2025,
author = {Kim, Dae-Seok and Onodera, Toshiharu and Funcke, Jan-Bernd and Min, Kyounghee and Zhu, Qingzhang and Lin, Qian and Chen, Shiuhwei and Joung, Chanmin and Kim, Min and Wynn, R Max and Velasco, Joselin and Lee, Charlotte and Virostek, Megan and Li, Chao and Scherer, Philipp E},
title = {Inhibiting inflammation in adipocytes accelerates mammary tumor development in mice},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci187202}
}
EUVIMED